Predicting Postoperative Complications and Long-Term Survival After Lung Cancer Surgery Using Eurolung Risk Score
- PMID: 35132842
- PMCID: PMC8822110
- DOI: 10.3346/jkms.2022.37.e36
Predicting Postoperative Complications and Long-Term Survival After Lung Cancer Surgery Using Eurolung Risk Score
Abstract
Background: This study aimed to assess the clinical relevance of the parsimonious Eurolung risk scoring system for predicting postoperative morbidity, mortality, and long-term survival in Korean patients with surgically resected non-small cell lung cancer.
Methods: This retrospective analysis used the data of patients who underwent anatomical resection for non-small cell lung cancer between 2004 and 2018 at a single institution. The parsimonious aggregate Eurolung score was calculated for each patient. The Cox regression model was used to determine the ability of the Eurolung scoring system for predicting long-term outcomes.
Results: Of the 7,278 patients in the study, cardiopulmonary complications and mortality occurred in 687 (9.4%) and 53 (0.7%) patients, respectively. The rate of cardiopulmonary complications and mortality gradually increased with the increase in the Eurolung risk scores (all P < 0.001). When risk scores were grouped into four categories, the Eurolung scoring system showed a stepwise deterioration of overall survival with the increase in risk scores, and this association was statistically significant (P < 0.001). Multivariate Cox analysis showed that the Eurolung scoring system, classified into four categories, was a significant prognostic factor of overall survival even after adjusting for covariates such as tumor histology and pathological stage (P < 0.001).
Conclusion: Stratification based on the parsimonious Eurolung scoring system showed good discriminatory ability for predicting postoperative morbidity, mortality, and long-term survival in South Korean patients with surgically resected non-small cell lung cancer. This might help clinicians to provide a detailed prognosis and decide the appropriate treatment option for high-risk patients with non-small cell lung cancer.
Keywords: Eurolung Risk Score; Lung Cancer; Postoperative Complication; Surgery.
© 2022 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures




Similar articles
-
Validation of Eurolung risk models in a Japanese population: a retrospective single-centre analysis of 612 cases.Interact Cardiovasc Thorac Surg. 2019 Nov 1;29(5):722-728. doi: 10.1093/icvts/ivz171. Interact Cardiovasc Thorac Surg. 2019. PMID: 31317181
-
Eurolung risk score is associated with long-term survival after curative resection for lung cancer.J Thorac Cardiovasc Surg. 2021 Mar;161(3):776-786. doi: 10.1016/j.jtcvs.2020.06.151. Epub 2020 Aug 24. J Thorac Cardiovasc Surg. 2021. PMID: 32948299 Free PMC article.
-
A comparative study of four thoracic mortality scores.Asian Cardiovasc Thorac Ann. 2023 Mar;31(3):244-252. doi: 10.1177/02184923231159086. Epub 2023 Mar 2. Asian Cardiovasc Thorac Ann. 2023. PMID: 36862589
-
External validation of risk prediction scores in patients undergoing anatomic video-assisted thoracoscopic resection.Surg Endosc. 2023 Apr;37(4):2789-2799. doi: 10.1007/s00464-022-09786-7. Epub 2022 Dec 7. Surg Endosc. 2023. PMID: 36477642 Free PMC article.
-
Parsimonious Eurolung risk models to predict cardiopulmonary morbidity and mortality following anatomic lung resections: an updated analysis from the European Society of Thoracic Surgeons database.Eur J Cardiothorac Surg. 2020 Mar 1;57(3):455-461. doi: 10.1093/ejcts/ezz272. Eur J Cardiothorac Surg. 2020. PMID: 31605105
Cited by
-
Real-world surgical treatment patterns and clinical outcomes in patients with stages IA-IIIA non-small cell lung cancer: a retrospective multicentric observational study involving 11,958 patients.J Cancer Res Clin Oncol. 2023 Sep;149(11):8213-8223. doi: 10.1007/s00432-023-04729-8. Epub 2023 Apr 16. J Cancer Res Clin Oncol. 2023. PMID: 37062036 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. - PubMed
-
- Brunelli A, Salati M, Rocco G, Varela G, Van Raemdonck D, Decaluwe H, et al. European risk models for morbidity (EuroLung1) and mortality (EuroLung2) to predict outcome following anatomic lung resections: an analysis from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2017;51(3):490–497. - PubMed
-
- Brunelli A, Cicconi S, Decaluwe H, Szanto Z, Falcoz PE. Parsimonious Eurolung risk models to predict cardiopulmonary morbidity and mortality following anatomic lung resections: an updated analysis from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2020;57(3):455–461. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical